SIA "Baltic Pharmabridge"Active
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2008–2025
| 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | ||||||||||||||||||
| Total current assets | 99 202 | 61 524 | 66 754 | 61 063 | 68 527 | 49 720 | 70 546 | 108 757 | 116 857 | 117 541 | 131 430 | 129 922 | 114 203 | 83 806 | 84 179 | 80 464 | 124 495 | 117 089 |
| Total non-current assets | 426 267 | 454 147 | 445 160 | 437 708 | 429 132 | 419 314 | 582 978 | 569 581 | 556 516 | 543 452 | 530 387 | 517 323 | 504 259 | 492 259 | 480 259 | 468 259 | 456 259 | 444 259 |
| Total assets | 525 469 | 515 671 | 511 914 | 498 771 | 497 659 | 469 034 | 653 524 | 678 338 | 673 373 | 660 993 | 661 817 | 647 245 | 618 462 | 576 065 | 564 438 | 548 723 | 580 754 | 561 348 |
| Balance sheet — liabilities and equity | ||||||||||||||||||
| Current liabilities | 219 480 | 210 901 | 255 234 | 213 392 | 214 468 | 214 720 | 298 699 | 296 701 | 294 319 | 288 118 | 286 595 | 294 470 | 289 705 | 295 743 | 289 657 | 254 988 | 271 753 | 289 220 |
| Non-current liabilities | 334 340 | 319 240 | 258 590 | 271 240 | 255 940 | 214 942 | 270 835 | 263 835 | 233 835 | 212 074 | 185 673 | 146 026 | 122 026 | 63 026 | 55 026 | 56 026 | 48 026 | 25 026 |
| Total liabilities | 553 820 | 530 141 | 513 824 | 484 632 | 470 408 | 429 662 | 569 534 | 560 536 | 528 154 | 500 192 | 472 268 | 440 496 | 411 731 | 358 769 | 344 683 | 311 014 | 319 779 | 314 246 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -8311 | 11 422 | 12 560 | 16 049 | 13 112 | 12 121 | 27 969 | 33 811 | 27 418 | 15 582 | 28 747 | 17 200 | -18 | 10 565 | 2459 | 17 954 | 23 266 | -13 873 |
| Total equity | -28 351 | -14 470 | -1910 | 14 139 | 27 251 | 39 372 | 83 990 | 117 802 | 145 219 | 160 801 | 189 549 | 206 749 | 206 731 | 217 296 | 219 755 | 237 709 | 260 975 | 247 102 |
| Income statement | ||||||||||||||||||
| Sales revenue | 23 631 | 32 308 | 39 057 | 40 414 | 39 886 | 44 039 | 69 511 | 73 944 | 68 351 | 66 694 | 68 009 | 63 304 | 44 419 | 46 087 | 69 618 | 76 255 | 96 042 | 175 919 |
| Operating profit | -7433 | 12 630 | 15 838 | 17 926 | 17 412 | 21 536 | 33 289 | 39 565 | 27 418 | 15 973 | 28 747 | 17 200 | -18 | 10 565 | 2459 | 17 954 | 23 266 | -13 873 |
| Profit before income tax | -7602 | 12 180 | 14 866 | 18 167 | 15 675 | 14 687 | 33 252 | 39 094 | 27 418 | 15 973 | 28 747 | 17 200 | -18 | 10 565 | 2459 | 17 954 | 23 266 | -13 873 |
| Profit for the reporting year | -8311 | 11 422 | 12 560 | 16 049 | 13 112 | 12 121 | 27 969 | 33 811 | 27 418 | 15 582 | 28 747 | 17 200 | -18 | 10 565 | 2459 | 17 954 | 23 266 | -13 873 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | ||||||||||||||||||
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Calculated dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Related companies
- SIA "Innova Medicina" — 27%
Summary: SIA "Baltic Pharmabridge"
Overview
SIA "Baltic Pharmabridge" (reg. no. 40003763729) is a limited liability company. The company was registered in 2005 and has been in the register for 21 years. Registered address: Rīga, Matīsa iela 103A.
Financial results
Revenue in 2025 was 175 919 €, up 83,2% on the previous year (96 042 €). From 2008 to 2025, revenue grew by an average of 12,5% per year. This is the company's highest revenue among the published years (2008–2025). 2025 ended with a loss of 13 873 €. The company was profitable in 15 of the 18 published years. In 2025 the company had 2 employees. Revenue per employee was 87 960 €. At the end of 2025, total assets were 561 348 € and equity 247 102 € (44,0% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual. The company holds a stake in one other active Latvian company.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.